European Multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori

被引:268
作者
Glupczynski, Y
Mégraud, F
Lopez-Brea, M
Andersen, LP
机构
[1] Clin Univ UCL Mont Godinne, Bacteriol Lab, B-5530 Yvoir, Belgium
[2] Hop Pellegrin, Bacteriol Lab, F-33076 Bordeaux, France
[3] Hosp Princesa, Dept Clin Microbiol, Madrid, Spain
[4] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark
关键词
D O I
10.1007/s100960100611
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A multicentre in vitro survey was carried out in 1998 in 22 European centres in order to assess the variation in the prevalence of Helicobacter pylori resistance. The susceptibility of 1,274 isolates to metronidazole, clarithromycin and amoxicillin was determined by the E test. The mean rate of resistance to metronidazole was 33.1% (95% CI 7.5-58.9), to clarithromycin 9.9% (95% CI, 0-28.1) and to amoxicillin 0.8% (95% CI, 0-8.9). Resistance to metronidazole was significantly higher in females (P<0.001), while resistance to clarithromycin was significantly higher in children and teens (P<0.05). Resistance to both agents also tended to be higher in strains isolated from patients from southern European countries than in those isolated from patients from central or northern Europe. Overall, these results emphasize the need for further surveys of Helicobacter pylori sensitivity to antibiotics at a national and regional level.
引用
收藏
页码:820 / 823
页数:4
相关论文
共 15 条
[1]   Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin -: Influence on treatment outcome [J].
Adamek, RJ ;
Suerbaum, S ;
Pfaffenbach, B ;
Opferkuch, W .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (03) :386-389
[2]  
[Anonymous], M100S10 NCCLS
[3]  
Batnavala N, 1994, GUT, V35, P1562
[4]   Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance [J].
Buckley, MJM ;
Xia, HX ;
Hyde, DM ;
Keane, CT ;
OMorain, CA .
DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (10) :2111-2115
[5]   Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands [J].
Debets-Ossenkopp, YJ ;
Herscheid, AJ ;
Pot, RGJ ;
Kuipers, EJ ;
Kusters, JG ;
Vandenbroucke-Grauls, CMJE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (04) :511-515
[6]   Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy -: A meta-analytical approach [J].
Dore, MP ;
Leandro, G ;
Realdi, G ;
Sepulveda, AR ;
Graham, DY .
DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (01) :68-76
[7]   Helicobacter pylori [J].
Dunn, BE ;
Cohen, H ;
Blaser, MJ .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (04) :720-+
[8]  
Glupczynski Y, 1998, ACTA GASTRO-ENT BELG, V61, P357
[9]  
GLUPCZYNSKI Y, 1992, EUR J CLIN MICROBIOL, V11, P777
[10]  
Glupczynski Y, 1998, GUT, V43, pA47